Indatuximab

NEW

Item number	Size	Datasheet	Manual	SDS	Delivery time	Price
TGM-T77377-1mg	1 mg	-	-	-	7 - 10 business days*	235.00€
TGM-T77377-5mg	5 mg	-	-	-	7 - 10 business days*	707.00€
TGM-T77377-10mg	10 mg	-	-	-	7 - 10 business days*	1,137.00€
TGM-T77377-25mg	25 mg	-	-	-	7 - 10 business days*	1,848.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Indatuximab is a chimeric antibody targeting CD13, used in the synthesis of ADC... more

Close menu

Product information "Indatuximab"

Description: Indatuximab is a chimeric antibody targeting CD13, used in the synthesis of ADC compound Indatuximab ravtansine. Target: Integrin. References: Finks SW, et al. Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant. Am J Med. 2017 May,130(5):e195-e197.

Supplier:	TargetMol
Supplier-Nr:	T77377

Properties

MW:

145.5 kD

Database Information

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Indatuximab"

Write a review